Greater Fool Theory The greater fool theory states that

New Post Public Reply Private Reply Replies (0) Message Board
joey68
220
Greater Fool Theory

The greater fool theory states that the price of an object is determined not by its intrinsic value, but rather by irrational beliefs and expectations of market participants (investors).

A price can be justified by a rational buyer under the belief that another party is willing to pay an even higher price.

In other words, one may pay a price that seems "foolishly" high because one may rationally have the expectation that the item can be resold to a "greater fool" later.

To make it as simple as possible.. We never see ourselves as the 'fool' until it's too late.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Scienjoy's Strategic Stake in Education: Bold Move?

Updated Category News Views 1

Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 3

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Battling Razor Bumps: Breaking a Persistent Cycle

Updated Category News Views 4

Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 3

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 4

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Qapture Expands Global DeFi Reach with Key Acquisitions

Updated Category News Views 2

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Continue Reading
Intrigue Over Guadalupe River Property Bid

Updated Category News Views 2

Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 2

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Three Lions Acquisition Corp: $100M IPO Hits Nasdaq

Updated Category News Views 3

Three Lions Joins the SPAC Playground The market's buzzing today as Three Lions Acquisition Corp. sauntered in with a $100M debut. Yep, they're the latest Special Purpose Acquisition Company out to net some big fish in the sports, hospitality, and real estate waters. A blank check company raising this kind of dough ain't exactly a novelty, but it never fails to turn a few...

Continue Reading
Epson & The Photo Managers Highlight Memories in Sept.

Updated Category News Views 8

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading